Persistence of HIV-1 Transmitted Drug Resistance Mutations (original) (raw)
Persistence of Transmitted HIV-1 Drug Resistance Mutations
Valentina Cambiano
The Journal of Infectious Diseases, 2013
View PDFchevron_right
Frequency and Treatment‐Related Predictors of Thymidine‐Analogue Mutation Patterns in HIV‐1 Isolates after Unsuccessful Antiretroviral Therapy
Paolo Almi
The Journal of Infectious Diseases, 2006
View PDFchevron_right
Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study
Steven Schnittman
PLoS ONE, 2010
View PDFchevron_right
Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa
Tina Ramatsebe
AIDS Research and Human Retroviruses, 2012
View PDFchevron_right
Evolution of Human Immunodeficiency Virus Type 1 (HIV1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV1Infected Patients Switched to Antiretroviral Therapy without NNRTIs
Xavier Duval
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Limited Evolution of HIV Antiretroviral Drug Resistance-Associated Mutations During the Performance of Drug Resistance Testing
tracey middleton
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
View PDFchevron_right
Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes
Ricardo Flores Diaz
Journal of Infectious Diseases, 2011
View PDFchevron_right
Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility
Robert Shafer
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance
Philip Tzou
Viruses, 2021
View PDFchevron_right
HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey
bahadır ceylan
AIDS Research and Human Retroviruses, 2016
View PDFchevron_right
Risk of Selecting De Novo Drug-Resistance Mutations during Structured Treatment Interruptions in Patients with Chronic HIV Infection
Pedro Castro
Clinical Infectious Diseases, 2005
View PDFchevron_right
HIV Drug Resistance Mutations in Patients with HIV and HIV-TB Coinfection After Failure of First-Line Therapy: A Prevalence Study in a Resource-Limited Setting
Nawaid Khan
Journal of the International Association of Providers of AIDS Care (JIAPAC), 2019
View PDFchevron_right
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Barbara Hasse
The Journal of Infectious Diseases, 2015
View PDFchevron_right
Changing Patterns in HIV Reverse Transcriptase Resistance Mutations after Availability of Tenofovir
Carolina Garrido
Clinical Infectious Diseases, 2008
View PDFchevron_right
Primary HIV-1 resistance: Persistence of transmitted drug resistance mutations
D. Jevtović
Archives of Biological Sciences, 2012
View PDFchevron_right
Comparison of the Dynamics of Resistance-Associated Mutations to Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors after Cessation of Antiretroviral Combination Therapy
Christine Katlama
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Changing Rates and Patterns of Drug Resistance Mutations in Antiretroviral-Experienced HIV-Infected Patients
Germán Ramírez Olivencia
AIDS Research and Human Retroviruses, 2007
View PDFchevron_right
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy
Simona Giulia Signorini
Journal of Clinical Laboratory Analysis, 2001
View PDFchevron_right
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure
Lorenzo Bracciale
Infection, 2011
View PDFchevron_right
Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Variants with Insertions or Deletions in the Reverse Transcriptase (RT): Multicenter Study of Patients Treated with RT Inhibitors
Ali Mohammed
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK
Gary Murphy
Journal of Antimicrobial Chemotherapy, 2016
View PDFchevron_right
Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression
Terese Katzenstein
Scandinavian Journal of Infectious Diseases, 2005
View PDFchevron_right
Long‐Term Probability of Detecting Drug‐Resistant HIV in Treatment‐Naive Patients Initiating Combination Antiretroviral Therapy
Sara Burns
Clinical Infectious Diseases, 2010
View PDFchevron_right
Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy
ISAAC ADEWOLE
AIDS Research and Human Retroviruses, 2011
View PDFchevron_right
Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1
Francesca Falasca
2015
View PDFchevron_right
The K101P and K103R/V179D Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nonnucleoside Reverse Transcriptase Inhibitors
Soumi Gupta
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Predictors for the Emergence of the 2 Multi-nucleoside/nucleotide Resistance Mutations 69 Insertion and Q151M and their Impact on Clinical Outcome in the Swiss HIV Cohort Study
Philippe Burgisser
Journal of Infectious Diseases, 2011
View PDFchevron_right
Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource‐Limited Settings
Johan Bruun
The Journal of Infectious Diseases, 2009
View PDFchevron_right